CE

Celanese (CE)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:CE
DataOraFonteTitoloSimboloCompagnia
17/05/202422:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CECelanese Corporation
15/05/202422:35Edgar (US Regulatory)Form 8-K - Current reportNYSE:CECelanese Corporation
09/05/202416:00Business WireCelanese Receives American Chemistry Council’s 2024 Sustainability Leadership Award for Achievements in CircularityNYSE:CECelanese Corporation
08/05/202422:15Business WireCelanese Corporation Reports First Quarter EarningsNYSE:CECelanese Corporation
22/04/202422:00Business WireCelanese Announces Kim K.W. Rucker as New Lead Independent DirectorNYSE:CECelanese Corporation
18/04/202422:00Business WireCelanese to Hold First Quarter Earnings Conference Call on May 9, 2024NYSE:CECelanese Corporation
17/04/202422:10Business WireCelanese Corporation Declares Quarterly Dividend of $0.70 Per ShareNYSE:CECelanese Corporation
16/04/202415:00Business WireChemical Marketing & Economics Honors Celanese Chairman, CEO and President Lori J. Ryerkerk with STEM Leadership Award for Corporate ReinventionNYSE:CECelanese Corporation
09/04/202415:00Business WireCelanese Completes Series of Strategic Actions Across its Global Acetyl ChainNYSE:CECelanese Corporation
21/03/202414:00Business WireCelanese Achieves ISCC CFC Certification for Low Carbon CCU MethanolNYSE:CECelanese Corporation
20/03/202414:00Business WireCelanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense TherapiesNYSE:CECelanese Corporation
08/03/202414:52Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNYSE:CECelanese Corporation
29/02/202415:00Business WireCelanese Announces Commercial Launch of Glaukos' iDose® TR (Travoprost Intracameral Implant) Using Celanese's VitalDose® Ethylene Vinyl Acetate (EVA)NYSE:CECelanese Corporation
28/02/202422:33Business WireTimothy Go Elected to Celanese Board of DirectorsNYSE:CECelanese Corporation
20/02/202422:15Business WireCelanese Corporation Reports Full Year 2023 and Fourth Quarter EarningsNYSE:CECelanese Corporation
12/02/202415:00Business WireCelanese Low-Carbon ECO-CC Products Available Through U.S. Department of Energy Procurement Grant ProgramNYSE:CECelanese Corporation
10/02/202400:19Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:CECelanese Corporation
10/02/202400:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:CECelanese Corporation
22/01/202415:00Business WireCelanese and Under Armour Develop Innovative New NEOLAST™ Fiber for Use in Performance Stretch FabricsNYSE:CECelanese Corporation
11/01/202422:15Business WireCelanese to Hold Fourth Quarter Earnings Conference Call on February 21, 2024NYSE:CECelanese Corporation
09/01/202415:00Business WireCelanese Begins Carbon Capture and Utilization Operations at Clear Lake, Texas, FacilityNYSE:CECelanese Corporation
17/11/202322:12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:CECelanese Corporation
16/11/202313:22IH Market NewsThursday’s Wall Street Highlights: Intel, Toyota, Catalent, Palo Alto Networks, Cisco, and moreNYSE:CECelanese Corporation
08/11/202322:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:CECelanese Corporation
06/11/202323:26Business WireCelanese Corporation Reports Third Quarter 2023 EarningsNYSE:CECelanese Corporation
06/11/202322:15Business WireCelanese Announces New Leadership Appointments to Enhance Value CreationNYSE:CECelanese Corporation
18/10/202322:30Business WireGanesh Moorthy Elected to Celanese Board of DirectorsNYSE:CECelanese Corporation
04/10/202322:15Business WireCelanese to Hold Third Quarter Earnings Conference Call on November 7, 2023NYSE:CECelanese Corporation
27/09/202322:15Business WireCelanese Completes the Formation of Nutrinova, a Food Ingredients Joint Venture with MitsuiNYSE:CECelanese Corporation
12/09/202315:30Business WireCelanese Announces Agreement with the Population Council for Sustained Release Dual-API TherapeuticNYSE:CECelanese Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:CE
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network